Skip to main content
. 2019 Aug 23;10:840. doi: 10.3389/fphar.2019.00840

Figure 2.

Figure 2

The proposed interplay between CD33 and TREM2 in microglial phagocytosis. CD33 and TREM2 have been proposed to be inhibitors or activators of microglial phagocytosis, respectively. For TREM2, activating antibodies, and for CD33, inhibitory antibodies, have been proposed as therapeutic interventions. Figure created with Biorender.com